Advanced Filter

Filter by Group

Filter by Market Availability

Displaying drugs 15476 - 15500 of 15594 in total
Investigational
Matched Iupac: … (1S,3'R,6'R,7'R,8'E,11'S,12'R)-7'-{[(9aR)-octahydro-1H-pyrido[1,2-a]pyrazin-2-yl]methyl}-6-chloro-7'- …
Experimental
Patidegib has been investigated for the treatment of Conventional Chondrosarcoma.
Investigational
Doramapimod is a P38 MAP kinase inhibitor.
Investigational
Zanapezil (TAK-147) is a selective acetylcholine (ACh) esterase inhibitor under investigation as a drug for Alzheimer's disease (AD) treatment.
Investigational
Albaconazole has been used in trials studying the basic science of Onychomycosis.
Investigational
Experimental
Investigational
A phosphodiesterase inhibitor with antidepressant properties.
Investigational
Etamivan (INN) or ethamivan (USAN) is marketed under the name Analepticon. Etamvin is a respiratory stimulant drug similar to nikethamide. It is no longer used in the United States.
Withdrawn
Vestipitant has been investigated for the treatment of Tinnitus.
Investigational
Experimental
Experimental
Matched Iupac: … 3,15-dimethoxy-7,9,11,13-tetramethyl-16-oxo-1-oxacyclohexadeca-4,6,12,14-tetraen-2-yl]pentan-2-yl]-5-methyl
An IgG1 murine monoclonal anti-idiotype antibody (Ab2), ACA-125, was developed to bind to anti-CA 125 antibodies. ACA-125 mimics the tumor-associated antigen CA-125, which can be detected in about 80% of ovarian carcinomas. This new concept of oncological immunotherapy consists of an attempt to trigger the immune system of the host...
Investigational
Matched Description: … To create ACA-125, a hybridoma cell was adapted to serum-free medium and antibody was produced in a hollow …
Displaying drugs 15476 - 15500 of 15594 in total